Literature DB >> 30661347

Pathogenesis of Human Norovirus Genogroup II Genotype 4 in Post-Weaning Gnotobiotic Pigs.

Byung-Joo Park1, Soon-Tag Jung2, Chang-Sun Choi2, JinJong Myoung3, Hee-Seop Ahn1, Sang-Hoon Han1, Yong-Hyun Kim1, Hyeon-Jeong Go1, Joong-Bok Lee1, Seung-Yong Park1, Chang-Seon Song1, Sang-Won Lee1, In-Soo Choi1.   

Abstract

Norovirus is the most common cause of acute gastroenteritis. Its pathogenesis is poorly understood owing to the difficulty of establishing viral infection in animal models. Here, post-weaning gnotobiotic pigs were infected with human norovirus genogroup II genotype 4 (HuNoV GII.4) to investigate the pathogenesis and replication of the virus. Three groups of four pigs were infected with 1 × 10⁵, 1 × 10⁶, or 1 × 10⁷ genomic equivalent (GE) copies of HuNoV GII.4. Four pigs were used as negative controls. Blood and rectal swab samples were collected after viral infection, and gross legions were examined after necropsy. Diarrhea was induced in 25% and 75% of pigs infected with 1 × 10⁶ and 1 × 10⁷ GE copies, respectively. Viral shedding was detected in 50%, 75%, and 50% of pigs infected with 1 × 10⁵, 1 × 10⁶, and 1 × 10⁷ GE copies, respectively. Viremia was detected in 25% of pigs infected with either 1 × 10⁶ or 1 × 10⁷ GE copies. When gross lesions of gastroenteritis were investigated, the ileum walls of the infected pigs were thinner than those of the controls. Villi atrophy and inflammatory cell infiltration were identified in the ileum of each infected pig. Viral capsid was identified in the jejunum, ileum, colon, spleen, and mesenteric lymph node. Virus replication was newly verified in the spleen and mesenteric lymph nodes by detection of negative-sense viral RNA. In conclusion, HuNoV GII.4 could induce acute gastroenteritis and replicate in the extraintestinal lymphoid tissues in post-weaning gnotobiotic pigs. Therefore, such pigs would be a suitable animal model for studying the pathogenesis and replication of HuNoV.

Entities:  

Keywords:  Norovirus; gastroenteritis; gnotobiotic pig; pathogenesis; replication

Mesh:

Substances:

Year:  2018        PMID: 30661347     DOI: 10.4014/jmb.1809.09061

Source DB:  PubMed          Journal:  J Microbiol Biotechnol        ISSN: 1017-7825            Impact factor:   2.351


  7 in total

Review 1.  Advances in understanding of the innate immune response to human norovirus infection using organoid models.

Authors:  Wadzanai P Mboko; Preeti Chhabra; Marta Diez Valcarce; Veronica Costantini; Jan Vinjé
Journal:  J Gen Virol       Date:  2022-01       Impact factor: 3.891

2.  Human Noroviruses Attach to Intestinal Tissues of a Broad Range of Animal Species.

Authors:  Nele Villabruna; Claudia M E Schapendonk; Georgina I Aron; Marion P G Koopmans; Miranda de Graaf
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

Review 3.  Human Norovirus: Experimental Models of Infection.

Authors:  Kyle V Todd; Ralph A Tripp
Journal:  Viruses       Date:  2019-02-12       Impact factor: 5.048

Review 4.  Animals as Reservoir for Human Norovirus.

Authors:  Nele Villabruna; Marion P G Koopmans; Miranda de Graaf
Journal:  Viruses       Date:  2019-05-25       Impact factor: 5.048

5.  Analysis of the Immune Responses in the Ileum of Gnotobiotic Pigs Infected with the Recombinant GII.p12_GII.3 Human Norovirus by mRNA Sequencing.

Authors:  Byung-Joo Park; Hee-Seop Ahn; Sang-Hoon Han; Hyeon-Jeong Go; Dong-Hwi Kim; Changsun Choi; Soontag Jung; Jinjong Myoung; Joong-Bok Lee; Seung-Yong Park; Chang-Seon Song; Sang-Won Lee; Hoon-Taek Lee; In-Soo Choi
Journal:  Viruses       Date:  2021-01-11       Impact factor: 5.048

Review 6.  Noroviruses-The State of the Art, Nearly Fifty Years after Their Initial Discovery.

Authors:  Louisa F Ludwig-Begall; Axel Mauroy; Etienne Thiry
Journal:  Viruses       Date:  2021-08-04       Impact factor: 5.048

Review 7.  Swine Norovirus: Past, Present, and Future.

Authors:  Lara Cavicchio; Andrea Laconi; Alessandra Piccirillo; Maria Serena Beato
Journal:  Viruses       Date:  2022-03-05       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.